Archives
Cy5.5 NHS Ester: Advanced Near-Infrared Dye for Biomolecu...
Cy5.5 NHS Ester (Non-Sulfonated): Revolutionizing Near-Infrared Biomolecule Labeling for Tumor Imaging and Beyond
Overview: Principle and Setup of Cy5.5 NHS Ester Labeling
Cy5.5 NHS ester (non-sulfonated) stands at the forefront of modern molecular imaging, offering a potent combination of chemical specificity, near-infrared (NIR) fluorescence, and compatibility with diverse biomolecules. Designed for the covalent labeling of peptides, proteins, and oligonucleotides containing primary amine groups, this reagent utilizes N-hydroxysuccinimide (NHS) ester chemistry to form stable amide bonds. Its distinctive excitation maximum at 684 nm and emission at 710 nm (cy5 5 excitation emission) minimize background autofluorescence, making it a premier near-infrared fluorescent dye for biomolecule labeling—especially in complex biological matrices and deep tissue environments.
The Cy5.5 NHS ester (non-sulfonated) dye’s low aqueous solubility is counterbalanced by exceptional solubility in organic solvents such as DMF and DMSO (≥35.82 mg/mL in DMSO), supporting versatile conjugation protocols across a wide range of experimental needs. The dye is supplied as a solid, with a shelf-life of 24 months when stored at -20°C in the dark—parameters that ensure long-term reliability for demanding research programs.
Step-by-Step Workflow Enhancements for Reliable Labeling
1. Preparation of Dye and Biomolecule
- Dissolution: Dissolve the Cy5.5 NHS ester immediately before use in dry DMSO or DMF to the desired working concentration (typically 1–10 mM). Protect from light to preserve dye integrity.
- Buffer Selection: Prepare your protein or oligonucleotide sample in an amine-free buffer such as PBS (pH 7.2–8.5) without Tris, glycine, or other competing amines. For oligonucleotide labeling, ensure the presence of a primary amine modification at the desired conjugation site.
2. Conjugation Reaction
- Reaction Setup: Slowly add the dye solution to the biomolecule solution (molar ratio 3–10:1 dye:biomolecule recommended for proteins; optimize empirically for nucleic acids).
- Incubation: Allow the reaction to proceed at room temperature for 30–60 minutes with gentle mixing, shielded from light. For sensitive proteins, reactions at 4°C may be preferable.
3. Purification
- Desalting or Chromatography: Remove unreacted dye using size-exclusion columns, dialysis, or spin filters (10 kDa MWCO for most proteins; desalting columns for oligonucleotides). This step is critical for reducing background fluorescence in downstream imaging.
- Quality Control: Verify conjugation efficiency by UV-Vis spectroscopy (A280 and A684) and/or SDS-PAGE for proteins. Typical dye:protein ratios of 2–4 are readily achievable, as supported by literature and product usage reports.
4. Storage
- Aliquot and Freeze: Store labeled conjugates in small aliquots at -20°C, protected from light. Avoid repeated freeze-thaw cycles to maintain fluorescence intensity.
Advanced Applications and Comparative Advantages in Tumor Imaging
The near-infrared emission profile of Cy5.5 NHS ester (excitation/emission: 684/710 nm) makes it an ideal fluorescent dye for protein conjugation and in vivo fluorescence imaging, particularly in oncology and immunology. A landmark study (Kang et al., 2025) leveraged NIR-labeled probes to visualize vaccine distribution and monitor the efficacy of polyvalent nanovaccines in selectively eradicating tumor-associated bacteria. The use of Cy5.5 NHS ester as a tumor imaging agent enabled high-contrast delineation of tumor margins and real-time tracking in live animal models, providing pivotal data on vaccine pharmacokinetics and tissue targeting.
Compared to visible-range dyes, Cy5.5 NHS ester delivers:
- Deeper tissue penetration: NIR fluorescence avoids tissue autofluorescence and light scattering, supporting high-resolution imaging several centimeters below the skin surface.
- Enhanced multiplexing: Its unique spectral profile allows combination with other fluorophores (e.g., Cy3, Cy7) for multi-target studies in molecular biology and diagnostics.
- Superior photostability: Robust signal retention during prolonged imaging sessions and repeated exposures.
These advantages are further reinforced by scenario-driven protocols in the article Optimizing Cell Assays with Cy5.5 NHS Ester (Non-Sulfonated), which details how this dye enhances sensitivity and reproducibility in cell viability and cytotoxicity assays, complementing tumor imaging strategies with robust cell-based readouts.
For deeper mechanistic and translational context, the piece Illuminating the Invisible: Strategic Integration of Cy5.5 NHS Ester discusses how Cy5.5 NHS ester enables next-generation research at the intersection of tumor biology and microbiome modulation—an extension of its demonstrated value in vaccine and immunotherapy workflows.
Case Example: Quantitative Imaging in Vaccine Development
In the referenced Science Advances study, NIR-labeled vaccine formulations facilitated quantitative in vivo imaging, allowing researchers to monitor biodistribution and immune response kinetics. Labeled nanovaccines displayed sustained tumor accumulation and high signal-to-noise ratios, critical for validating therapeutic efficacy and optimizing dosing in preclinical models. These findings underscore Cy5.5 NHS ester’s unique suitability for translational oncology and immunology.
Troubleshooting and Optimization Tips for Cy5.5 NHS Ester Labeling
- Low Labeling Efficiency: Confirm that the biomolecule solution is free of competing amines (avoid Tris, glycine, or ammonium buffers). Increase the molar excess of dye or extend incubation time if needed.
- Dye Precipitation: Always dissolve Cy5.5 NHS ester first in a dry organic solvent (DMSO or DMF). Add the dye solution slowly while mixing, and maintain the reaction volume <5% organic solvent to prevent protein denaturation.
- High Background Fluorescence: Ensure thorough purification post-labeling. Use spin columns or multiple buffer exchanges to eliminate free dye, particularly before in vivo applications.
- Signal Fading: Protect all conjugates and working solutions from prolonged light exposure. Store aliquots at -20°C, and avoid repeated freeze-thaw cycles.
- Batch-to-Batch Variation: Quantify labeling efficiency after each preparation using absorbance at 684 nm; adjust future reaction parameters accordingly. Document and standardize buffer conditions to ensure reproducibility.
For additional guidance on optimizing molecular imaging and bio-conjugation workflows, the article Translating Mechanistic Insight into Molecular Precision provides a blueprint for ensuring data quality and experimental robustness, offering troubleshooting strategies that extend and complement those described here.
Future Outlook: Expanding the Utility of Near-Infrared Fluorescent Labeling
As the field of molecular imaging evolves, the demand for robust, high-sensitivity, and multiplex-compatible labeling reagents like Cy5.5 NHS ester will continue to grow. Its unique combination of chemical reactivity, NIR fluorescence, and compatibility with a wide array of biomolecules positions it as a cornerstone in the next generation of precision diagnostics, live-cell imaging, and therapeutic monitoring.
Emerging applications include multiplexed immunophenotyping, real-time tracking of therapeutic delivery, and integration into advanced nanovaccine platforms for targeted microbiome modulation and cancer prevention. As demonstrated in the recent Science Advances study, the ability to non-invasively quantify vaccine biodistribution and efficacy in vivo paves the way for smarter, data-driven development of translational therapies.
APExBIO’s commitment to product quality and user support ensures that Cy5.5 NHS ester (non-sulfonated) remains at the cutting edge of fluorescent labeling in molecular biology, empowering researchers to illuminate the invisible and push the boundaries of what’s possible in life sciences.